Regulation (EU) 2019/6 on veterinary medicinal products entered into force in January 2022 and has fundamentally restructured the European animal health market. The regulation banned routine prophylactic antibiotic use in feed, restricted preventive antibiotic group treatment, established new pharmacovigilance requirements, and harmonized approval pathways across EU member states. Implementation continues through 2026 with significant impact on livestock production, parasiticide markets, and supplier strategy. The European Medicines Agency (EMA) Committee for Veterinary Medicinal Products (CVMP) sets technical standards across the EU.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• EU 2019/6 Regulation Overview and Implementation Timeline
• Antimicrobial Restrictions — Prophylactic and Group Treatment Bans
• Centralized Approval Pathway via EMA CVMP
• Mutual Recognition and Decentralized Procedures
• Veterinary Medicinal Product Pharmacovigilance
• Antimicrobial Sales Reporting and Reduction Targets
• Cascade and Off-Label Use Provisions
• Compounding and Magistral Formulation Rules
• Generic Pathway and Patent Linkage in EU
• National Regulatory Variation Within Harmonized Framework
Table of Contents
1. Executive Summary
2. Market Overview
3. EU 2019/6 Regulation Overview
4. Antimicrobial Restrictions
5. Centralized Approval Pathway
6. Mutual Recognition Procedures
7. Pharmacovigilance
8. Sales Reporting and Reduction Targets
9. Cascade and Off-Label Use
10. Compounding Rules
11. Generic Pathway
12. National Variation
13. Market Challenges and Risks
14. Strategic Conclusions and Recommendations
15. Appendix
List of Tables
Table 1. EU 2019/6 Implementation Timeline and Key Provisions
Table 2. Antimicrobial Sales Trends Post-2019/6 by Country
Table 3. EMA CVMP Centralized Approvals 2023-2026
Table 4. Mutual Recognition Activity by Country
Table 5. Pharmacovigilance Requirements by Product Category
Table 6. Antimicrobial Reduction Targets by Country
Table 7. Cascade Use Volume by Indication
Table 8. Compounding Volume by Country
Table 9. Generic Animal Health Product Approvals in EU
Table 10. National Regulatory Variation Index
Companies Profiled
Boehringer Ingelheim Animal Health
Ceva Santé Animale
Dechra Pharmaceuticals
Elanco Animal Health
Merck Animal Health
Vetoquinol
Virbac
Zoetis
